Use access key #2 to skip to page content.
$0.92 0.07 (8.24%)
11/21/2008 4:00 PM

Caliper Life Sciences, Inc. (CALP)

CAPS Rating:
*

The Company sells products, services and integrated systems comprised of instruments, software and reagents to life sciences, biomedical and pharmaceutical researchers.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

Ticker Not Ratable

CALP doesn't currently meet the $100M market cap / $1.50 stock price minimum. (Learn More)

What the Community Thinks

Total Members

25 Outperforms
14 Underperforms
 

All-Stars

7 Outperforms
9 Underperforms
 

Wall Street

2 Outperforms
0 Underperforms
 

Members bullish on CALP are also bullish on:

Members bearish on CALP are also bearish on:

Ticker Tags

Micro Cap (5043), Life Sciences Tools and Services (59), Research Services (8), Technical Instruments (65)
Suggest a tag

Caliper Life Sciences, Inc. At A Glance

Current Price: $0.92
Last Trade Time: 11/21/2008 4:00 PM
Open: $0.87
Previous Close: $0.85
Daily Range: $0.63 - $1.06
52-Week Range: $0.85 - $5.94
Volume: 320,475
Market Cap: $41.17M
P/E Ratio: 0.00
Compare Our Special Broker Offers!

Stock Trends

CALP VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for CALP

More Headlines...

Top Bull Pitch

Recs

2

Caliper Life Sciences, Inc. (CALP)

Avatar julianwain (93.92) Submitted: 3/07/07 2:54 PM

Caliper is acquiring many companies in an attempt to become a full provider for the pre-clinical part of the R&D drug cycle.
Acquired Xenogen a short time ago. It is the leader in its area and competitors can't keep up with them: incorporates competitors' advantages very quickly and maintains own co...More

Replies: 2 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 8 :   1 2 Next »

Recs

0

 (CALP)

Avatar JerichoHill (63.09) Submitted: 5/30/08 7:52 AM : Outperform Start Price: $3.49 CALP Score: -27.56

Maptitude appears to be gaining an edge on its rival ESRI amongst government agencies looking ahead to the Census redistricting

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (CALP)

Avatar FlorisHJ (93.81) Submitted: 5/09/08 5:50 PM : Underperform Start Price: $3.20 CALP Score: 25.71

per recent quarterly earnings call, they are running out of cash... will need to raise money (dilutive) or go under completely

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (CALP)

Avatar bclan13 (99.44) Submitted: 11/26/07 1:17 AM : Outperform Start Price: $5.32 CALP Score: -35.21

CALP's IP position is solid, and their value proposition, namely providing highly standardized research services on an outsourced basis, has great potential.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (CALP)

Avatar OneStarHero (< 20) Submitted: 5/27/07 12:27 PM : Outperform Start Price: $4.87 CALP Score: -31.02

Liquid handling is cool

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (CALP)

Avatar msamet1 (96.77) Submitted: 3/30/07 11:02 AM : Underperform Start Price: $5.58 CALP Score: 36.79

Historic stock price ranged in present price; research reagent market has traditionally had low profit margins and slow revenue growth

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 8 :   1 2 Next »

Wall Street

Results 1 - 2 of 2  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackSoros < 20 09/30/07 Outperform NS $5.74-83.97%-50.30%-33.67 Toggle the visibility of 60-Second Pitch and replies
TrackLeerinkSwan 92.44 06/19/07 Outperform NS $4.50-79.56%-50.27%-29.29

Results 1 - 2 of 2  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

Sponsored Links